VP16-213 as a single agent in advanced testicular tumors.
D004341:Drug Evaluation; D004407:Dysgerminoma / Q000188:drug therapy / Q000556:secondary; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013724:Teratoma / Q000188:drug therapy / Q000556:secondary; D013736:Testicular Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
D005047:Etoposide; D011034:Podophyllotoxin